Investor insights
Funding rounds participated in
$5.5M sweet spot round size
Most of their 2 investments are in rounds between $1M and $10M
Basic info
Industry
pharmaceutical manufacturing
Sectors
Biotechnology
Health Care
RNA interference
Biotech
alpha one anti-trypsin deficiency
hepatitis B
Drug delivery
Pharmaceutical
Drug Development
Nanotechnology
Pharmaceuticals
Date founded
2004
Investments made
U
Undisclosed raised $1M on January 18, 2011
Investors: Arrowhead Pharmaceuticals, Inc.
U
Undisclosed raised $10M on April 4, 2006
Investors: Arrowhead Pharmaceuticals, Inc.
Funding rounds raised
Total raised
$60M
from 4 investors over 4 rounds
A
Arrowhead Pharmaceuticals, Inc. raised $9.6M on January 10, 2017
Investors: Silence Therapeutics plc
A
Arrowhead Pharmaceuticals, Inc. raised $45M on August 16, 2016
Investors: OrbiMed Advisors
A
Arrowhead Pharmaceuticals, Inc. raised $60M on October 14, 2013
Investors: RA Capital Management, L.P.
A
Arrowhead Pharmaceuticals, Inc. raised $17M on May 21, 2007
Investors: York Capital Management